Egbaria Kamel 4
4 · HI TECH PHARMACAL CO INC · Filed May 24, 2013
Insider Transaction Report
Form 4
Egbaria Kamel
Chief Scientific Officer, EVP
Transactions
- Award
Stock Option (Right to Buy)
2013-05-22+40,000→ 40,000 totalExercise: $33.81From: 2014-05-22Exp: 2023-05-22→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2012 Incentive Compensation Plan, which is a Rule 16b-3 Plan.
- [F2]The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- [F3]Other than the option reflected on this form, the filer is also the holder of additional options to acquire 148,658 shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices and exercisable and expiration dates.